Andersen Sune Bangsbøll, Törnberg Sven, Lynge Elsebeth, Von Euler-Chelpin My, Njor Sisse Helle
Department of Public Health, University of Copenhagen, CSS, Øster Farimagsgade 5, 1014 Copenhagen K, Denmark.
BMC Cancer. 2014 Oct 24;14:782. doi: 10.1186/1471-2407-14-782.
The sensitivity of a mammography program is normally evaluated by comparing the interval cancer rate to the expected breast cancer incidence without screening, i.e. the proportional interval cancer rate (PICR). The expected breast cancer incidence in absence of screening is, however, difficult to estimate when a program has been running for some time. As an alternative to the PICR we propose the interval cancer ratio ICR=intervalcancersintervalcancers+screendetectedcancers. We validated this simple measure by comparing it with the traditionally used PICR.
We undertook a systematic review and included studies: 1) covering a service screening program, 2) women aged 50-69 years, 3) observed data, 4) interval cancers, women screened, or interval cancer rate, screen detected cases, or screen detection rate, and 5) estimated breast cancer incidence rate of background population. This resulted in 5 papers describing 12 mammography screening programs.
Covering initial screens only, the ICR varied from 0.10 to 0.28 while the PICR varied from 0.22 to 0.51. For subsequent screens only, the ICR varied from 0.22 to 0.37 and the PICR from 0.28 to 0.51. There was a strong positive correlation between the ICR and the PICR for initial screens (r = 0.81), but less so for subsequent screens (r = 0.65).
This alternate measure seems to capture the burden of interval cancers just as well as the traditional PICR, without need for the increasingly difficult estimation of background incidence, making it a more accessible tool when evaluating mammography screening program performance.
乳腺钼靶筛查项目的敏感性通常通过将间期癌发生率与未进行筛查时预期的乳腺癌发病率进行比较来评估,即比例间期癌发生率(PICR)。然而,当一个项目运行一段时间后,未进行筛查时预期的乳腺癌发病率很难估计。作为PICR的替代方法,我们提出间期癌比率ICR = 间期癌数 /(间期癌数 + 筛查发现的癌数)。我们通过将其与传统使用的PICR进行比较,验证了这一简单指标。
我们进行了一项系统综述,纳入的研究需满足:1)涵盖一项服务性筛查项目;2)年龄在50 - 69岁的女性;3)观察数据;4)间期癌、接受筛查的女性、或间期癌发生率、筛查发现的病例、或筛查发现率;5)背景人群的估计乳腺癌发病率。这产生了5篇描述12个乳腺钼靶筛查项目的论文。
仅涵盖初次筛查时,ICR在0.10至0.28之间变化,而PICR在0.22至0.51之间变化。仅针对后续筛查时,ICR在0.22至0.37之间变化,PICR在0.28至0.51之间变化。初次筛查时ICR与PICR之间存在强正相关(r = 0.81),但后续筛查时相关性较弱(r = 0.65)。
这种替代指标似乎与传统的PICR一样,能够很好地反映间期癌的负担,且无需日益困难的背景发病率估计,使其在评估乳腺钼靶筛查项目性能时成为一种更易于使用的工具。